Smirking pharma-bro Martin Shkreli first came to public attention when he hiked the price of a drug used by people with HIV from $13.50/pill to $750/pill.
When Shkreli's financial antics landed him in prison, he packed the board of his pharma company with cronies who maintained his 50% ownership stake in the company. But Shrkeli isn't getting rich while he rots in prison: instead, his company Vyera Pharma (formerly Turing Pharma, soon to be rebranded, again, as Phoenixus, no, really) is spurting uncontrollable gouts of money from every orifice.
That's because the population of patients who take Daraprim -- the drug Shkreli gouged on -- is dwindling, and the remaining patients can't get their insurers to pay $750/pill.
The company’s revenue, which is largely reliant on Daraprim sales, peaked in 2016, reaching more than $78.5 million on the year and helping the company to a profit of $1.3 million. Sales slipped to $67 million in 2017. The company managed a $13.9 million profit thanks to a few one-time benefits and double-digit cuts to expenses and R&D investment.
But Daraprim’s negative sales trends seem to be catching up to Vyera. In the first quarter of 2018, the company booked just $15.7 million in sales. And, for the first time since the price hike, the company’s expenses outpaced its revenue, resulting in a loss of $1.2 million on the quarter.
Three years after steep price hike, Martin Shkreli’s drug company is losing money, documents show [Damian Garde and Adam Feuerstein/Stat]
(via Naked Capitalism)
Last year, California was one of several states to introduce right to repair legislation that would force companies to end practices that discourage the independent repair sector, creating a requirement to sell replacement parts, provide documentation, and supply codes to bypass DRM systems that locked new parts out of devices until the company activated them.
The term "meritocracy" was popularized in the UK sociologist Michael Young's 1958 novel, "The Rise of the Meritocracy," in which aristocrats insist that they are the natural rulers of their society based on "objective" measures of worth ("merit" + "aristocracy" = "meritocracy") that are obviously tilted to favor them, a fact that they are conveniently […]
A year ago, smarting over public criticism of its role in promoting division and stoking racism, Facebook announced a major shift in its newsfeed algorithm which would downrank posts from media organizations and uprank the things sent by your friends on the network, in the name of promotion a gentler form of "engagement" that would […]
Seems like drones are doing a lot of jobs these days, from reconnaissance to delivery. Now, we can add “keeping the Death Star safe” to that list. Whether you’re a drone enthusiast or a Star Wars fan, these Star Wars Propel Drones are undeniably the coolest toy around. Yes, that’s a fully functional drone replica […]
It’s spring clearance time for the Boing Boing Store, when some of the best deals from the holidays return even cheaper than before. From top-rated apps to educational software to the cutest record player of all time, they’re all back with a little extra incentive. Shop your heart out before tax season wraps up! Use […]
Big companies want automation on a big scale. Doing that means diving into the tricky world of machine learning and data science. And no matter what platform you’ll be implementing it on, you can learn how with the Machine Learning & Data Science Certification Training Bundle. In 48 hours and through eight courses, this bundle […]